公开(公告)号：US20210147381A1

公开(公告)日：2021-05-20

申请号：US16630813

申请日：2018-07-16

申请人： AbbVie Deutschland GmbH & Co. KG

发明人： Wilhelm AMBERG ,  Hervé GENESTE ,  Wilfried HORNBERGER ,  Udo LANGE ,  Mario MEZLER ,  Michael OCHSE ,  Frank OELLIEN ,  Sean C. TURNER ,  Jeroen VAN BERGEIJK ,  Elizabeth VAN DER KAM

IPC分类号： C07D401/06 ,  C07D217/02 ,  C07D409/06

摘要： The invention relates to 1,2,3,4-substituted quinoline compounds as S1P modulators, pharmaceutical compositions comprising such compounds, and uses thereof in the treatment, alleviation or prevention of diseases or disorders mediated by an S1P receptor.